Sun Pharmaceutical Industries Limited

This study is testing whether an injectable drug called tildrakizumab can safely reduce symptoms of active psoriatic arthritis. It will involve about 296 adults with the condition who have not previously tried a common class of arthritis drugs (anti-TNFs). Participants will recei…

This Phase 3 trial is testing whether regular injections of the drug tildrakizumab can safely clear skin and reduce itching in adults with moderate to severe genital psoriasis. The study will compare the drug against a placebo in about 206 participants. The main goal is to see if…

This study is testing a medication called tildrakizumab to see if it can effectively and safely control moderate-to-severe plaque psoriasis in children and teenagers aged 6 to 18. It will compare the drug against a placebo (an inactive substance) and another approved treatment. T…

This study continues monitoring patients who previously participated in tildrakizumab trials for psoriatic arthritis. Researchers are tracking 529 participants to understand the drug's long-term safety and how well it continues to control joint pain and swelling over time. The st…

This study aims to understand how a prescription acne cream (clascoterone 1%) works by looking at changes in facial oil glands. Researchers will take small skin samples and analyze facial oil from 10 adults with moderate acne before and after 3 months of treatment. The goal is to…